Neopharma Technologies recognised as the Top 100 Healthcare Technology company in 2021. Leading the way in Drugs-of-Abuse Testing.
Neopharma Technologies Ltd is the owner and operator of a globally patented, trademarked, and “award-winning” Drugs-of-Abuse testing device and Enterprise Resource Management platform:
TamperLoks DataVault. Today Neopharma announced that it has been included in The Healthcare Technology Reports’s Top 100 Technology Companies of 2021 list.
“It is a true honour for our company to be recognised alongside such distinguished & respected companies such as Johnson & Johnson, Boston Scientific, Abbott, and 3M” said Shaun Melville Global Head of Sales & Marketing for Neopharma Technologies.
“Neopharma Technologies is committed to creating a global safe workplace best practice solution with its world leading Drugs-of-Abuse testing solution TamperLoks DataVault. The impact of the Covid-19 pandemic has highlighted the importance of increased rapid testing and how that data can be managed in real time. Neopharma Technologies has entered the market to change the way this information is securely collected, transferred, stored, managed, and reported. As the company develops to increase its market share in the Global Drugs-of-Abuse testing industry, it is looking at how to better safely and securely manage the data of all critical health-related IVD’s including Covid19, Dengue Fever, HIV to name a few”.
The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on healthcare technology and the various companies, executives and investors that make up the sector.